NEW YORK (GenomeWeb) – Patients of any risk group may choose noninvasive cell-free DNA-based prenatal screening for common aneuploidies, but conventional screening methods "remain the most appropriate choice" for most pregnant women in the general population, according to a new committee opinion by the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine.

In addition, NIPT should not be used to screen for microdeletion syndromes routinely and is not recommended for women with multiple gestations, according to the organizations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.